معرفی
Husseini Manji is an Adjunct Professor of Psychiatry at Yale University's Yale School of Medicine. His primary affiliation is with the Department of Psychiatry. His work focuses on advancements in mental health, particularly depression treatment and neuropharmacology. He has contributed to notable developments in antidepressant medications, as highlighted in a 2024 article in PharmaVoice.
Research interests include innovative pharmaceutical approaches to mental health disorders, with a focus on ketamine-derived therapies. No specific grants, advising roles, or labs are explicitly mentioned in the provided text.
۰مقاله منتشرشده
